FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.

Organogenesis Holdings said its product for non-healing diabetic foot ulcers met the primary endpoint in a recent trial. The medicine company said Monday that PuraPly plus standard of care (SOC) ...

Shares of Organogenesis Holdings were higher after the company said its product for non-healing diabetic foot ulcers met its primary endpoint in a recent trial. The stock rose 30%, to $2.91, in ...

Mouth ulcer or oral cancer? Watch this video to know what experts say about the early warning signs of tongue and buccal ...

It’s really painful each time she says something to me. I’m afraid to hurt her feelings. She doesn’t seem to be worried about ...

One of the members of a support group has told me five times now that I should let my hair grow because it looks better ...

Organogenesis Holdings Inc. ORGO shares are up during Tuesday’s premarket session following the company’s announcement of achieving the primary endpoint in a randomized controlled trial evaluating ...

Dear Advice: Try not to worry too much about hurting her feelings, not as a vindictive act but because her feelings in this ...

The presentations will showcase new preclinical and clinical data supporting EscharEx’s differentiated mechanism of action, clinical performance, and advancement of its ongoing Phase III development ...

Following encounters while diving, Gusnar Ismail has long turned to the morning glory plants growing on sandbanks here on the ...

Dear Unsolicited Advice: Try not to worry too much about hurting her feelings, not as a vindictive act but because her ...

I am a widow of 10 years, and I have an opportunity to meet with a gentleman who is 80 and would like to have some sort of ...